CN118207464B - Entropy alloy material for promoting bone TiZrCoCrMoCu to resist bacteria and preparation method thereof - Google Patents
Entropy alloy material for promoting bone TiZrCoCrMoCu to resist bacteria and preparation method thereof Download PDFInfo
- Publication number
- CN118207464B CN118207464B CN202410613492.5A CN202410613492A CN118207464B CN 118207464 B CN118207464 B CN 118207464B CN 202410613492 A CN202410613492 A CN 202410613492A CN 118207464 B CN118207464 B CN 118207464B
- Authority
- CN
- China
- Prior art keywords
- alloy
- particles
- antibacterial
- tizrcocrmocu
- cocrmo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/04—Metals or alloys
- A61L27/06—Titanium or titanium alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/02—Inorganic materials
- A61L31/022—Metals or alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22C—ALLOYS
- C22C1/00—Making non-ferrous alloys
- C22C1/02—Making non-ferrous alloys by melting
- C22C1/03—Making non-ferrous alloys by melting using master alloys
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22C—ALLOYS
- C22C30/00—Alloys containing less than 50% by weight of each constituent
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22C—ALLOYS
- C22C30/00—Alloys containing less than 50% by weight of each constituent
- C22C30/02—Alloys containing less than 50% by weight of each constituent containing copper
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/12—Materials or treatment for tissue regeneration for dental implants or prostheses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Mechanical Engineering (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Metallurgy (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
技术领域Technical Field
本发明属于抗菌材料技术领域,特别涉及一种促成骨TiZrCoCrMoCu抗菌中熵合金材料及其制备方法。The invention belongs to the technical field of antibacterial materials, and particularly relates to an osteogenic TiZrCoCrMoCu antibacterial medium-entropy alloy material and a preparation method thereof.
背景技术Background technique
骨骼问题,如骨折、骨缺损和关节病变等,极大地降低了人们的健康水平和生活品质。在治疗这些疾病时,骨修复植入手术是骨科医学中的一种常用策略。然而,骨修复植入体的长期稳定性、生物相容性以及术后感染的防治仍然是亟待解决的关键问题。Bone problems, such as fractures, bone defects, and joint diseases, greatly reduce people's health and quality of life. Bone repair implant surgery is a common strategy in orthopedic medicine to treat these diseases. However, the long-term stability, biocompatibility, and prevention of postoperative infection of bone repair implants remain key issues that need to be addressed.
在骨科植入领域,常用的材料主要包括不锈钢、钴铬钼(CoCrMo)合金以及钛(Ti)合金等。得益于其出色的生物相容性、耐腐蚀特性、高强度和低弹性模量(介于80 GPa至160GPa之间),钛合金已经逐渐成为金属植入材料的优先选择。相比之下,不锈钢316L和Co-Cr-Mo合金的弹性模量均超过200 GPa,远高于钛合金。钛合金较低的弹性模量使得植入体与骨组织之间的应力更加均匀分布,有利于减轻“应力屏蔽”现象导致的骨吸收和植入体松动问题。然而,钛合金植入体存在的缺陷不可忽视:首先,现有的低弹性模量钛合金通常包含如铌(Nb)、钽(Ta)等高熔点且价格昂贵的金属元素,这会导致其制备成本较高。其次,钛合金的耐磨性较差,在人体生理环境中因发生摩擦腐蚀等问题,从而释放出微小的金属颗粒,导致周围组织发炎进而影响患者健康。与钛合金相比,CoCrMo合金虽然具有更高的弹性模量,但其出色的耐磨性表现确保了在长期使用中的稳定性。In the field of orthopedic implants, commonly used materials include stainless steel, cobalt-chromium-molybdenum (CoCrMo) alloys, and titanium (Ti) alloys. Thanks to its excellent biocompatibility, corrosion resistance, high strength, and low elastic modulus (between 80 GPa and 160 GPa), titanium alloys have gradually become the preferred choice of metal implant materials. In contrast, the elastic modulus of stainless steel 316L and Co-Cr-Mo alloys are both over 200 GPa, much higher than that of titanium alloys. The lower elastic modulus of titanium alloys makes the stress between the implant and the bone tissue more evenly distributed, which helps to reduce the bone absorption and implant loosening caused by the "stress shielding" phenomenon. However, the defects of titanium alloy implants cannot be ignored: First, the existing low elastic modulus titanium alloys usually contain high melting point and expensive metal elements such as niobium (Nb) and tantalum (Ta), which leads to high preparation costs. Secondly, titanium alloys have poor wear resistance. In the physiological environment of the human body, due to problems such as friction corrosion, tiny metal particles are released, causing inflammation of the surrounding tissues and affecting the health of patients. Although CoCrMo alloy has a higher elastic modulus compared to titanium alloy, its excellent wear resistance ensures its stability in long-term use.
上述传统骨科植入体材料在医疗实践中广泛应用并取得显著成效,但缺乏抗菌性限制了其在植入领域的发展。目前,全球每年因术后细菌感染而导致的医疗资源浪费以及治疗费用都是不可忽视的。当植入体材料不具备抗菌功能时,患者手术后更易遭受细菌感染,进而引起植入体松动乃至脱落,最终导致患者遭受健康和金钱的双重损失。因此,开发和研究具有良好抗菌性能的骨修复植入材料,对减少术后感染风险并提高植入体的长期成功率具有重要意义。The above-mentioned traditional orthopedic implant materials are widely used in medical practice and have achieved remarkable results, but the lack of antibacterial properties limits their development in the implant field. At present, the global waste of medical resources and treatment costs caused by postoperative bacterial infections each year cannot be ignored. When the implant material does not have antibacterial function, patients are more susceptible to bacterial infection after surgery, which in turn causes the implant to loosen or even fall off, ultimately causing the patient to suffer a double loss of health and money. Therefore, the development and research of bone repair implant materials with good antibacterial properties is of great significance to reduce the risk of postoperative infection and improve the long-term success rate of implants.
基于上述背景,通过结合CoCrMo合金和钛合金的优势,并加入钛(Ti)、锆(Zr)元素和具有抗菌性能的铜(Cu)元素,成功开发一种新型的抗菌中熵合金,即TiZrCoCrMoCu合金。TiZrCoCrMoCu合金拥有Ti合金低模量和高生物相容性的同时,还获得了CoCr合金的高耐磨性能。针对CoCr合金长期使用时缓慢释放Co和Cr离子的问题,该合金减少了Co和Cr元素的含量,并利用中熵合金特有的迟滞扩散效应,显著减缓这些元素的扩散速率。Zr元素具有良好的生物相容性,能够与Ti无限互溶。Cu元素则赋予合金强大的抗菌能力,通过破坏细菌细胞膜、抑制细菌生长,从而降低感染的可能性。Based on the above background, a new type of antibacterial medium-entropy alloy, TiZrCoCrMoCu alloy, was successfully developed by combining the advantages of CoCrMo alloy and titanium alloy, and adding titanium (Ti), zirconium (Zr) elements and copper (Cu) elements with antibacterial properties. TiZrCoCrMoCu alloy has the low modulus and high biocompatibility of Ti alloy, and also obtains the high wear resistance of CoCr alloy. In view of the problem that CoCr alloy slowly releases Co and Cr ions during long-term use, the alloy reduces the content of Co and Cr elements, and utilizes the hysteresis diffusion effect unique to medium-entropy alloys to significantly slow down the diffusion rate of these elements. Zr element has good biocompatibility and can be infinitely miscible with Ti. Cu element gives the alloy strong antibacterial ability, which reduces the possibility of infection by destroying bacterial cell membranes and inhibiting bacterial growth.
综上所述,本专利申请旨在提供一种促进骨抗菌钛合金的制备方法及其应用,为骨修复领域的技术进步和临床治疗提供有力支持。。In summary, this patent application aims to provide a preparation method and application of bone-promoting antibacterial titanium alloy, and to provide strong support for technological progress and clinical treatment in the field of bone repair.
发明内容Summary of the invention
针对现有技术中的问题,本发明提供一种促成骨TiZrCoCrMoCu抗菌中熵合金及其制备方法,主要目的在于设计获得同时具有抗菌功能性和优异促成骨性能的抗菌中熵合金。In view of the problems in the prior art, the present invention provides an osteopromoting TiZrCoCrMoCu antibacterial medium-entropy alloy and a preparation method thereof, the main purpose of which is to design an antibacterial medium-entropy alloy having both antibacterial functionality and excellent osteopromoting performance.
为达到上述目的,本发明所采用的技术方案如下:In order to achieve the above object, the technical solution adopted by the present invention is as follows:
一种促成骨TiZrCoCrMoCu抗菌中熵合金材料的制备方法,包括如下步骤:A method for preparing a bone-promoting TiZrCoCrMoCu antibacterial medium-entropy alloy material comprises the following steps:
步骤1:制备CoCrMo中间合金Step 1: Preparation of CoCrMo master alloy
将Co、Cr和Mo颗粒以目标合金成分原子数百分比进行配比,预处理后进行两次以上熔炼,得到稳定CoCrMo中间合金,将所述CoCrMo中间合金切割成颗粒;Co, Cr and Mo particles are mixed in proportion to the target alloy component atomic percentage, and smelted twice or more after pretreatment to obtain a stable CoCrMo master alloy, and the CoCrMo master alloy is cut into particles;
步骤2:抗菌中间合金的制备Step 2: Preparation of antibacterial master alloy
如果目标合金中Cu的原子数百分比大于0,按目标合金成分原子数百分比混合Ti、Cu颗粒,预处理后进行两次以上熔炼,切割成抗菌中间合金颗粒,为A合金颗粒;If the atomic percentage of Cu in the target alloy is greater than 0, Ti and Cu particles are mixed according to the atomic percentage of the target alloy components, smelted twice or more after pretreatment, and cut into antibacterial master alloy particles, which are A alloy particles;
如果目标合金中Cu的原子数百分比等于0,Ti颗粒即为A合金颗粒;If the atomic percentage of Cu in the target alloy is equal to 0, the Ti particle is the A alloy particle;
步骤3:终体合金的制备Step 3: Preparation of final alloy
将CoCrMo中间合金颗粒和A合金颗粒混合,Zr颗粒放置于顶部,CoCrMo中间合金颗粒和A合金颗粒置于底部,预处理后进行两次以上熔炼,得到具有促进骨和抗菌功能的TiZrCoCrMoCu合金。The CoCrMo master alloy particles and the A alloy particles are mixed, the Zr particles are placed on the top, and the CoCrMo master alloy particles and the A alloy particles are placed on the bottom. After pretreatment, smelting is performed more than twice to obtain a TiZrCoCrMoCu alloy with bone-promoting and antibacterial functions.
所述步骤1、2、3中预处理过程为:在真空环境下多次使用氩气冲洗原料金属颗粒;真空度为10-4Pa。The pretreatment process in steps 1, 2 and 3 is: flushing the raw metal particles with argon gas for multiple times in a vacuum environment; the vacuum degree is 10 -4 Pa.
所述步骤1、2中,所有原料金属颗粒纯度需在99.9% (wt.%)以上,将金属颗粒使用酒精超声清洗去油污,并在通风橱中进行干燥处理,使金属颗粒表面没有氧化皮等异物。In steps 1 and 2, the purity of all raw metal particles must be above 99.9% (wt.%), the metal particles are ultrasonically cleaned with alcohol to remove oil and dirt, and dried in a fume hood to ensure that there is no foreign matter such as oxide scale on the surface of the metal particles.
所述步骤1、2、3中,原料金属颗粒为直径2 mm,长度3 mm的小圆柱,其中抗菌中间合金中Cu的原子分数为40%~50%。In the steps 1, 2 and 3, the raw metal particles are small cylinders with a diameter of 2 mm and a length of 3 mm, wherein the atomic fraction of Cu in the antibacterial master alloy is 40% to 50%.
所述步骤1、2、3中,所述熔炼的温度为1400~1800 ℃,熔炼时间为50~65 s,翻转一次后重新熔炼。In the steps 1, 2 and 3, the smelting temperature is 1400-1800° C., the smelting time is 50-65 s, and the smelting is repeated after turning over once.
一种促成骨TiZrCoCrMoCu抗菌中熵合金材料,采用上述方法制得,所述合金材料的化学通式为TiaZrbCocCrdMoeCuf(at.%),其中,33<a≤45,33<b≤45,11<c≤15,5<d≤10,0.5<e≤2,0≤f≤10。A bone-promoting TiZrCoCrMoCu antibacterial medium-entropy alloy material is prepared by the method. The general chemical formula of the alloy material is Ti a Zr b Co c Cr d Mo e Cu f (at.%), wherein 33<a≤45, 33<b≤45, 11<c≤15, 5<d≤10, 0.5<e≤2, and 0≤f≤10.
优选的,所述促成骨TiZrCoCrMoCu抗菌中熵合金材料的压缩强度为1242~1435MPa,弹性模量为94~105 GPa;对表面粘附的大肠杆菌抗菌率达95.1%。Preferably, the bone-promoting TiZrCoCrMoCu antibacterial medium-entropy alloy material has a compressive strength of 1242-1435 MPa and an elastic modulus of 94-105 GPa; and an antibacterial rate of 95.1% against surface-adherent Escherichia coli.
优选的,小鼠成骨细胞(MT3T3细胞)与所述促成骨TiZrCoCrMoCu抗菌中熵合金材料共培养第3、5、7天后的细胞增殖率远高于纯Ti,且其表面成骨细胞形态和细胞密度亦比纯Ti更优异。Preferably, the cell proliferation rate of mouse osteoblasts (MT3T3 cells) co-cultured with the osteogenic TiZrCoCrMoCu antibacterial medium-entropy alloy material after 3, 5, and 7 days is much higher than that of pure Ti, and its surface osteoblast morphology and cell density are also better than those of pure Ti.
与现有技术相比,本发明具有下列有益效果:Compared with the prior art, the present invention has the following beneficial effects:
本发明通过真空熔炼技术,依据抗菌中间合金中Cu的原子分数调整熔炼功率和时间,并加入CoCrMo中间合金,通过翻转重熔工艺完成抗菌中熵合金的制备。该合金设计允许Ti、Zr、Co、Cr、Mo、Cu等元素的原子分数在较宽范围内调整,以达到强度、弹性模量、抗菌性和细胞相容性之间的最佳匹配,适合于多种应用场景。与传统的医用植入材料相比,本发明的制备过程更为简化,不需复杂热处理,且由于不包含Nb、Ta等难熔贵金属,降低了合金的熔点和提高了铸造性能,有效减少成本。该合金结合了钛合金的优良生物相容性和低弹性模量以及CoCr合金的出色耐磨性。Cu的添加赋予了合金抗菌性能,由于中熵合金的缓慢扩散效应,Cu元素会缓慢的扩散到合金周围环境中。这种特殊效应在不增加细胞毒性的同时,还显著降低了植入物手术的感染风险,从而促进患者伤口愈合和恢复。The present invention uses vacuum melting technology to adjust the melting power and time according to the atomic fraction of Cu in the antibacterial master alloy, and adds CoCrMo master alloy to complete the preparation of the antibacterial medium entropy alloy through a flip remelting process. The alloy design allows the atomic fractions of elements such as Ti, Zr, Co, Cr, Mo, and Cu to be adjusted within a wide range to achieve the best match between strength, elastic modulus, antibacterial properties and cell compatibility, and is suitable for a variety of application scenarios. Compared with traditional medical implant materials, the preparation process of the present invention is simpler, does not require complex heat treatment, and because it does not contain refractory precious metals such as Nb and Ta, it reduces the melting point of the alloy and improves the casting performance, effectively reducing costs. The alloy combines the excellent biocompatibility and low elastic modulus of titanium alloys with the excellent wear resistance of CoCr alloys. The addition of Cu gives the alloy antibacterial properties, and due to the slow diffusion effect of the medium entropy alloy, the Cu element will slowly diffuse into the surrounding environment of the alloy. This special effect significantly reduces the infection risk of implant surgery without increasing cytotoxicity, thereby promoting wound healing and recovery in patients.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
图1是纯Ti样品与本发明实施例1-3所制备TiZrCoCrMoCu抗菌中熵合金ARS染色图;FIG1 is an ARS staining diagram of a pure Ti sample and the TiZrCoCrMoCu antibacterial medium entropy alloy prepared in Examples 1-3 of the present invention;
图2是纯Ti样品与本发明实施例1-3所制备TiZrCoCrMoCu抗菌中熵合金的抗菌平板涂布图;FIG2 is an antibacterial flat plate coating diagram of a pure Ti sample and the TiZrCoCrMoCu antibacterial medium entropy alloy prepared in Examples 1-3 of the present invention;
图3是纯Ti样品与本发明实施例1-3所制备TiZrCoCrMoCu抗菌中熵合金的抗菌率显著性分析图;3 is a significance analysis diagram of the antibacterial rate of the pure Ti sample and the TiZrCoCrMoCu antibacterial medium entropy alloy prepared in Examples 1-3 of the present invention;
图4是纯Ti样品与本发明实施例1-3所制备TiZrCoCrMoCu抗菌中熵合金的7天细胞增值率统计图;FIG4 is a statistical graph of the 7-day cell proliferation rate of a pure Ti sample and the TiZrCoCrMoCu antibacterial medium entropy alloy prepared in Examples 1-3 of the present invention;
图5是纯Ti、Cu样品与本发明实施例1-3所制备TiZrCoCrMoCu抗菌中熵合金的细胞骨架荧光染色图。FIG5 is a fluorescence staining image of the cytoskeleton of pure Ti, Cu samples and the TiZrCoCrMoCu antibacterial medium entropy alloy prepared in Examples 1-3 of the present invention.
具体实施方式Detailed ways
下面结合附图及具体实施例,进一步阐述本发明。应理解,这些实施例仅用于说明本发明而不用于限制本发明的范围。下列实施例中未注明具体条件的操作方法,通常按照常规条件。The present invention will be further described below in conjunction with the accompanying drawings and specific examples. It should be understood that these examples are only used to illustrate the present invention and are not intended to limit the scope of the present invention. The operating methods in the following examples that do not specify specific conditions are usually based on conventional conditions.
实施例1Example 1
本发明实施例提供一种促成骨TiZrCoCrMoCu抗菌中熵合金及其制备方法,化学通式为Ti40Zr40Co12.8Cr6.4Mo0.8(at.%),按上述抗菌中熵合金的化学式,计算出Ti、Zr、Co、Cr、Mo单质原料的添加量。其中,所使用的Ti、Zr、Co、Cr、Mo的单质原料纯度均达到99% (wt.%)以上。包括如下步骤:The embodiment of the present invention provides a bone-promoting TiZrCoCrMoCu antibacterial medium-entropy alloy and a preparation method thereof, wherein the general chemical formula is Ti 40 Zr 40 Co 12.8 Cr 6.4 Mo 0.8 (at.%), and the addition amount of Ti, Zr, Co, Cr, and Mo single-substance raw materials is calculated according to the chemical formula of the antibacterial medium-entropy alloy. The purity of the single-substance raw materials of Ti, Zr, Co, Cr, and Mo used is above 99% (wt.%). The preparation method comprises the following steps:
步骤1:制备CoCrMo中间合金Step 1: Preparation of CoCrMo master alloy
将Co、Cr和Mo颗粒经酒精超声波清洁脱脂和干燥,以目标合金成分原子数百分比进行配比,将称量好的Co、Cr和Mo颗粒装入磁悬浮感应熔炼炉的水冷铜坩埚内,经抽空排气至<0.001 Pa真空度后,在1.2 bar的氩气氛围保护下进行熔炼,熔炼温度为1800 ℃,熔炼时间为60秒,为使成分均匀,需翻身重复熔炼2次,得到稳定CoCrMo中间合金,将所述CoCrMo中间合金切割成颗粒;The Co, Cr and Mo particles are cleaned, degreased and dried by alcohol ultrasonic cleaning, and the proportions are made according to the atomic percentage of the target alloy components. The weighed Co, Cr and Mo particles are loaded into a water-cooled copper crucible of a magnetic suspension induction melting furnace, and after being evacuated to a vacuum degree of <0.001 Pa, they are melted under the protection of an argon atmosphere of 1.2 bar. The melting temperature is 1800°C and the melting time is 60 seconds. In order to make the composition uniform, the melting is repeated twice to obtain a stable CoCrMo master alloy, and the CoCrMo master alloy is cut into particles;
步骤2:终体合金的制备Step 2: Preparation of final alloy
将CoCrMo中间合金颗粒和称量好的Ti颗粒混合,Zr颗粒放置于顶部,CoCrMo中间合金颗粒和Ti合金颗粒置于底部,装入磁悬浮感应熔炼炉的水冷铜坩埚内,经抽空排气至<0.001 Pa真空度后,在1.2 bar的氩气氛围保护下进行熔炼,熔炼温度为1800 ℃,熔炼时间为60秒,为使成分均匀,需翻身重复熔炼2次,得到促成骨TiZrCoCrMo抗菌中熵合金材料。The CoCrMo master alloy particles and weighed Ti particles were mixed, Zr particles were placed on the top, CoCrMo master alloy particles and Ti alloy particles were placed on the bottom, and loaded into a water-cooled copper crucible of a magnetic levitation induction melting furnace. After evacuating the air to a vacuum degree of <0.001 Pa, they were melted under the protection of an argon atmosphere of 1.2 bar. The melting temperature was 1800 ℃ and the melting time was 60 seconds. In order to make the composition uniform, the melting was repeated twice to obtain the osteopromoting TiZrCoCrMo antibacterial medium-entropy alloy material.
实施例2Example 2
本发明实施例提供一种促成骨TiZrCoCrMoCu抗菌中熵合金及其制备方法,化学通式为Ti38Zr38Co12.16Cr6.08Mo0.76Cu5(at.%),按上述抗菌中熵合金的化学式,计算出Ti、Zr、Co、Cr、Mo、Cu单质原料的添加量。其中,所使用的Ti、Zr、Co、Cr、Mo、Cu的单质原料纯度均达到99% (wt.%)以上。包括如下步骤:The embodiment of the present invention provides a bone-promoting TiZrCoCrMoCu antibacterial medium-entropy alloy and a preparation method thereof, wherein the general chemical formula is Ti 38 Zr 38 Co 12.16 Cr 6.08 Mo 0.76 Cu 5 (at.%), and the addition amount of Ti, Zr, Co, Cr, Mo, and Cu single-substance raw materials is calculated according to the chemical formula of the antibacterial medium-entropy alloy. The purity of the single-substance raw materials of Ti, Zr, Co, Cr, Mo, and Cu used is above 99% (wt.%). The preparation method comprises the following steps:
步骤1:制备CoCrMo中间合金Step 1: Preparation of CoCrMo master alloy
将Co、Cr和Mo颗粒经酒精超声波清洁脱脂和干燥,以目标合金成分原子数百分比进行配比,将称量好的Co、Cr和Mo颗粒装入置于磁悬浮感应熔炼炉的水冷铜坩埚内,经抽空排气至<0.001 Pa真空度后,在1.2 bar的氩气氛围保护下进行熔炼,熔炼温度为1800 ℃,熔炼时间为60秒,为使成分均匀,需翻身重复熔炼2次,得到稳定CoCrMo中间合金,将所述CoCrMo中间合金切割成颗粒;The Co, Cr and Mo particles are cleaned, degreased and dried by alcohol ultrasonic cleaning, and the proportions are made according to the atomic percentage of the target alloy components. The weighed Co, Cr and Mo particles are loaded into a water-cooled copper crucible placed in a magnetic suspension induction melting furnace, and after being evacuated to a vacuum degree of <0.001 Pa, they are melted under the protection of an argon atmosphere of 1.2 bar. The melting temperature is 1800°C and the melting time is 60 seconds. In order to make the composition uniform, the melting is repeated twice to obtain a stable CoCrMo master alloy, and the CoCrMo master alloy is cut into particles;
步骤2:抗菌中间合金的制备Step 2: Preparation of antibacterial master alloy
将称量好的Ti颗粒和Cu颗粒按一定比例装入真空电弧炉或者真空感应炉的坩埚中,将Cu颗粒掩埋在Ti颗粒中,经抽空排气至<0.001 Pa真空度后,在1.2 bar的氩气氛围保护下进行熔炼,熔炼温度为1800 ℃,熔炼时间为60秒,为使成分均匀,需翻身重复熔炼2次,切割成抗菌中间合金颗粒,为A合金颗粒;The weighed Ti particles and Cu particles are loaded into a crucible of a vacuum arc furnace or a vacuum induction furnace in a certain proportion, and the Cu particles are buried in the Ti particles. After evacuation to a vacuum degree of <0.001 Pa, they are melted under the protection of an argon atmosphere of 1.2 bar. The melting temperature is 1800 °C and the melting time is 60 seconds. In order to make the composition uniform, the melting is repeated twice and cut into antibacterial intermediate alloy particles, which are alloy A particles.
步骤3:终体合金的制备Step 3: Preparation of final alloy
将CoCrMo中间合金颗粒和A合金颗粒混合,Zr颗粒放置于顶部,CoCrMo中间合金颗粒和A合金颗粒置于底部,装入磁悬浮感应熔炼炉的水冷铜坩埚内,经抽空排气至<0.001Pa真空度后,在1.2 bar的氩气氛围保护下进行熔炼,熔炼温度为1800 ℃,熔炼时间为60秒,为使成分均匀,需翻身重复熔炼2次,得到促成骨TiZrCoCrMoCu抗菌中熵合金铸锭。The CoCrMo master alloy particles and A alloy particles were mixed, Zr particles were placed on the top, CoCrMo master alloy particles and A alloy particles were placed on the bottom, and loaded into a water-cooled copper crucible of a magnetic levitation induction melting furnace. After evacuating the air to a vacuum degree of <0.001Pa, they were melted under the protection of an argon atmosphere of 1.2 bar. The melting temperature was 1800 ℃ and the melting time was 60 seconds. In order to make the composition uniform, the ingot was turned over and melted repeatedly twice to obtain a bone-promoting TiZrCoCrMoCu antibacterial medium-entropy alloy ingot.
实施例3Example 3
本发明实施例提供一种促成骨TiZrCoCrMoCu抗菌中熵合金及其制备方法,化学通式为Ti36Zr36Co11.52Cr5.76Mo0.72Cu10(at.%)。按上述抗菌中熵合金的化学式,计算出Ti、Zr、Co、Cr、Mo、Cu单质原料的添加量。其中,所使用的Ti、Zr、Co、Cr、Mo、Cu的单质原料纯度均达到99% (wt.%)以上。包括如下步骤:The embodiment of the present invention provides a bone-promoting TiZrCoCrMoCu antibacterial medium-entropy alloy and a preparation method thereof, wherein the general chemical formula is Ti 36 Zr 36 Co 11.52 Cr 5.76 Mo 0.72 Cu 10 (at.%). According to the chemical formula of the antibacterial medium-entropy alloy, the addition amount of Ti, Zr, Co, Cr, Mo, and Cu single-substance raw materials is calculated. Among them, the purity of the single-substance raw materials of Ti, Zr, Co, Cr, Mo, and Cu used is more than 99% (wt.%). The following steps are included:
步骤1:制备CoCrMo中间合金Step 1: Preparation of CoCrMo master alloy
将Co、Cr和Mo颗粒经酒精超声波清洁脱脂和干燥,以目标合金成分原子数百分比进行配比,将称量好的Co、Cr和Mo颗粒装入置于磁悬浮感应熔炼炉的水冷铜坩埚内,经抽空排气至<0.001 Pa真空度后,在1.2 bar的氩气氛围保护下进行熔炼,熔炼温度为1800 ℃,熔炼时间为60秒,为使成分均匀,需翻身重复熔炼2次,得到稳定CoCrMo中间合金,将所述CoCrMo中间合金切割成颗粒;The Co, Cr and Mo particles are cleaned, degreased and dried by alcohol ultrasonic cleaning, and the proportions are made according to the atomic percentage of the target alloy components. The weighed Co, Cr and Mo particles are loaded into a water-cooled copper crucible placed in a magnetic suspension induction melting furnace, and after being evacuated to a vacuum degree of <0.001 Pa, they are melted under the protection of an argon atmosphere of 1.2 bar. The melting temperature is 1800°C and the melting time is 60 seconds. In order to make the composition uniform, the melting is repeated twice to obtain a stable CoCrMo master alloy, and the CoCrMo master alloy is cut into particles;
步骤2:抗菌中间合金的制备Step 2: Preparation of antibacterial master alloy
将称量好的Ti颗粒和Cu颗粒按一定比例装入真空电弧炉或者真空感应炉的坩埚中,将Cu颗粒掩埋在Ti颗粒中,经抽空排气至<0.001 Pa真空度后,在1.2 bar的氩气氛围保护下进行熔炼,熔炼温度为1800 ℃,熔炼时间为60秒,为使成分均匀,需翻身重复熔炼2次,切割成抗菌中间合金颗粒,为A合金颗粒;The weighed Ti particles and Cu particles are loaded into a crucible of a vacuum arc furnace or a vacuum induction furnace in a certain proportion, and the Cu particles are buried in the Ti particles. After evacuation to a vacuum degree of <0.001 Pa, they are melted under the protection of an argon atmosphere of 1.2 bar. The melting temperature is 1800 °C and the melting time is 60 seconds. In order to make the composition uniform, the melting is repeated twice and cut into antibacterial intermediate alloy particles, which are alloy A particles.
步骤3:终体合金的制备Step 3: Preparation of final alloy
将CoCrMo中间合金颗粒和A合金颗粒混合,Zr颗粒放置于顶部,CoCrMo中间合金颗粒和A合金颗粒置于底部,装入磁悬浮感应熔炼炉的水冷铜坩埚内,经抽空排气至<0.001Pa真空度后,在1.2 bar的氩气氛围保护下进行熔炼,熔炼温度为1800 ℃,熔炼时间为60秒,为使成分均匀,需翻身重复熔炼2次,得到促成骨TiZrCoCrMoCu抗菌中熵合金铸锭。The CoCrMo master alloy particles and A alloy particles were mixed, Zr particles were placed on the top, CoCrMo master alloy particles and A alloy particles were placed on the bottom, and loaded into a water-cooled copper crucible of a magnetic levitation induction melting furnace. After evacuating the air to a vacuum degree of <0.001Pa, they were melted under the protection of an argon atmosphere of 1.2 bar. The melting temperature was 1800 ℃ and the melting time was 60 seconds. In order to make the composition uniform, the ingot was turned over and melted repeatedly twice to obtain a bone-promoting TiZrCoCrMoCu antibacterial medium-entropy alloy ingot.
实施例4Example 4
本发明实施例提供一种促成骨TiZrCoCrMoCu抗菌中熵合金及其制备方法,化学通式为Ti40Zr40Co12.8Cr6.4Mo0.8(at.%),也可写为(TiZr)80(Co64Cr32Mo4)20(at.%),其中Co64Cr32Mo4为已广泛用于医疗领域的ASTM F75合金。按上述抗菌中熵合金的化学式,计算出可以使用Ti、Zr、ASTM F75合金原料的添加量。其中,所使用的Ti、Zr的单质原料纯度均达到99% (wt.%)以上。包括如下步骤:The embodiment of the present invention provides a bone-promoting TiZrCoCrMoCu antibacterial medium-entropy alloy and a preparation method thereof, wherein the general chemical formula is Ti 40 Zr 40 Co 12.8 Cr 6.4 Mo 0.8 (at.%), which can also be written as (TiZr) 80 (Co 64 Cr 32 Mo 4 ) 20 (at.%), wherein Co 64 Cr 32 Mo 4 is an ASTM F75 alloy that has been widely used in the medical field. According to the chemical formula of the above antibacterial medium-entropy alloy, the addition amount of Ti, Zr, and ASTM F75 alloy raw materials that can be used is calculated. Among them, the purity of the single-substance raw materials of Ti and Zr used reaches 99% (wt.%) or more. The following steps are included:
步骤1:制备CoCrMo中间合金Step 1: Preparation of CoCrMo master alloy
将ASTM F75合金切割成直径2 mm,长度3 mm的颗粒后经酒精超声波清洁脱脂和干燥,得到稳定CoCrMo中间合金,即ASTM F75合金;The ASTM F75 alloy was cut into particles with a diameter of 2 mm and a length of 3 mm, and then cleaned, degreased and dried by alcohol ultrasonic cleaning to obtain a stable CoCrMo master alloy, namely, the ASTM F75 alloy;
步骤2:终体合金的制备Step 2: Preparation of final alloy
将CoCrMo中间合金颗粒和Ti合金颗粒混合,Zr颗粒放置于顶部,CoCrMo中间合金颗粒和Ti合金颗粒置于底部,装入磁悬浮感应熔炼炉的水冷铜坩埚内,经抽空排气至<0.001 Pa真空度后,在1.2 bar的氩气氛围保护下进行熔炼,熔炼温度为1800 ℃,熔炼时间为60秒,为使成分均匀,需翻身重复熔炼2次,得到促成骨TiZrCoCrMoCu抗菌中熵合金铸锭,此方法避免了熔炼Mo颗粒,可大幅提高熔炼成功率。CoCrMo master alloy particles and Ti alloy particles are mixed, Zr particles are placed on the top, CoCrMo master alloy particles and Ti alloy particles are placed on the bottom, and loaded into a water-cooled copper crucible of a magnetic levitation induction melting furnace. After evacuating the air to a vacuum degree of <0.001 Pa, they are melted under the protection of an argon atmosphere of 1.2 bar. The melting temperature is 1800 ℃ and the melting time is 60 seconds. In order to make the composition uniform, the ingot needs to be turned over and melted repeatedly twice to obtain a bone-promoting TiZrCoCrMoCu antibacterial medium-entropy alloy ingot. This method avoids the melting of Mo particles and can greatly improve the melting success rate.
实施例5Example 5
本发明实施例提供一种促成骨TiZrCoCrMoCu抗菌中熵合金及其制备方法,化学通式为Ti38Zr38Co12.16Cr6.08Mo0.76Cu5(at.%),也可写为(TiZr)76(Co64Cr32Mo4)19Cu5(at.%),其中Co64Cr32Mo4为已广泛用于医疗领域的ASTM F75合金。按上述抗菌中熵合金的化学式,计算出Ti、Zr、Cu单质和ASTM F75合金原料的添加量。上述抗菌中熵合金的化学式,计算出可以使用Ti、Zr、ASTM F75合金金相合金的制备。其中,所使用的Ti、Zr、Cu的单质原料纯度均达到99% (wt.%)以上。包括如下步骤:The embodiment of the present invention provides a bone-promoting TiZrCoCrMoCu antibacterial medium-entropy alloy and a preparation method thereof, wherein the general chemical formula is Ti 38 Zr 38 Co 12.16 Cr 6.08 Mo 0.76 Cu 5 (at.%), which can also be written as (TiZr) 76 (Co 64 Cr 32 Mo 4 ) 19 Cu 5 (at.%), wherein Co 64 Cr 32 Mo 4 is an ASTM F75 alloy that has been widely used in the medical field. According to the chemical formula of the above antibacterial medium-entropy alloy, the addition amount of Ti, Zr, Cu single substance and ASTM F75 alloy raw material is calculated. The chemical formula of the above antibacterial medium-entropy alloy is used to calculate the preparation of the metallographic alloy of Ti, Zr, and ASTM F75 alloy. Among them, the purity of the single substance raw materials of Ti, Zr, and Cu used reaches 99% (wt.%) or more. The following steps are included:
步骤1:制备CoCrMo中间合金Step 1: Preparation of CoCrMo master alloy
将ASTM F75合金切割成直径2 mm,长度3 mm的颗粒后经酒精超声波清洁脱脂和干燥,得到稳定CoCrMo中间合金,即ASTM F75合金;The ASTM F75 alloy was cut into particles with a diameter of 2 mm and a length of 3 mm, and then cleaned, degreased and dried by alcohol ultrasonic cleaning to obtain a stable CoCrMo master alloy, namely, the ASTM F75 alloy;
步骤2:抗菌中间合金的制备Step 2: Preparation of antibacterial master alloy
将称量好的Ti颗粒和Cu颗粒按一定比例装入磁悬浮感应熔炼炉或电弧炉的坩埚中,将Cu颗粒掩埋在Ti颗粒中,经抽空排气至<0.001 Pa真空度后,在1.2 bar的氩气氛围保护下进行熔炼,熔炼温度为1800 ℃,熔炼时间为60秒,为使成分均匀,需翻身重复熔炼2次,切割成抗菌中间合金颗粒;The weighed Ti particles and Cu particles are loaded into the crucible of a magnetic suspension induction melting furnace or an arc furnace in a certain proportion, and the Cu particles are buried in the Ti particles. After evacuating the air to a vacuum degree of <0.001 Pa, the particles are melted under the protection of an argon atmosphere of 1.2 bar. The melting temperature is 1800 °C and the melting time is 60 seconds. In order to make the composition uniform, the particles need to be turned over and melted twice, and then cut into antibacterial master alloy particles.
步骤3:终体合金的制备Step 3: Preparation of final alloy
将CoCrMo中间合金颗粒和抗菌中间合金颗粒混合,Zr颗粒放置于顶部,CoCrMo中间合金颗粒和抗菌中间合金颗粒置于底部,装入磁悬浮感应熔炼炉的水冷铜坩埚内,经抽空排气至<0.001 Pa真空度后,在1.2 bar的氩气氛围保护下进行熔炼,熔炼温度为1800℃,熔炼时间为60秒,为使成分均匀,需翻身重复熔炼2次,得到促成骨TiZrCoCrMoCu抗菌中熵合金铸锭,此方法避免了熔炼Mo颗粒,可大幅提高熔炼成功率。The CoCrMo master alloy particles and the antibacterial master alloy particles are mixed, the Zr particles are placed on the top, and the CoCrMo master alloy particles and the antibacterial master alloy particles are placed on the bottom, and are loaded into a water-cooled copper crucible of a magnetic levitation induction melting furnace. After evacuating the air to a vacuum degree of <0.001 Pa, they are melted under the protection of an argon atmosphere of 1.2 bar. The melting temperature is 1800°C and the melting time is 60 seconds. In order to make the composition uniform, the ingot needs to be turned over and melted repeatedly twice to obtain a bone-promoting TiZrCoCrMoCu antibacterial medium-entropy alloy ingot. This method avoids the melting of Mo particles and can greatly improve the melting success rate.
实施例6Example 6
本发明实施例提供一种促成骨TiZrCoCrMoCu抗菌中熵合金及其制备方法,化学通式为Ti36Zr36Co11.52Cr5.76Mo0.72Cu10(at.%),也可写为(TiZr)72(Co64Cr32Mo4)18Cu10(at.%),其中Co64Cr32Mo4为已广泛用于医疗领域的ASTM F75合金。按上述抗菌中熵合金的化学式,计算出Ti、Zr、Cu单质和ASTM F75合金原料的添加量。上述抗菌中熵合金的化学式,计算出可以使用Ti、Zr、ASTM F75合金金相合金的制备。其中,所使用的Ti、Zr、Cu的单质原料纯度均达到99% (wt.%)以上。包括如下步骤:The embodiment of the present invention provides a bone-promoting TiZrCoCrMoCu antibacterial medium-entropy alloy and a preparation method thereof, wherein the general chemical formula is Ti 36 Zr 36 Co 11.52 Cr 5.76 Mo 0.72 Cu 10 (at.%), which can also be written as (TiZr) 72 (Co 64 Cr 32 Mo 4 ) 18 Cu 10 (at.%), wherein Co 64 Cr 32 Mo 4 is an ASTM F75 alloy that has been widely used in the medical field. According to the chemical formula of the above antibacterial medium-entropy alloy, the addition amount of Ti, Zr, Cu single substance and ASTM F75 alloy raw material is calculated. The chemical formula of the above antibacterial medium-entropy alloy is used to calculate the preparation of the metallographic alloy of Ti, Zr, and ASTM F75 alloy. Among them, the purity of the single substance raw materials of Ti, Zr, and Cu used reaches 99% (wt.%) or more. The following steps are included:
步骤1:制备CoCrMo中间合金Step 1: Preparation of CoCrMo master alloy
将ASTM F75合金切割成直径2 mm,长度3 mm的颗粒后经酒精超声波清洁脱脂和干燥,得到稳定CoCrMo中间合金,即ASTM F75合金;The ASTM F75 alloy was cut into particles with a diameter of 2 mm and a length of 3 mm, and then cleaned, degreased and dried by alcohol ultrasonic cleaning to obtain a stable CoCrMo master alloy, namely, the ASTM F75 alloy;
步骤2:抗菌中间合金的制备Step 2: Preparation of antibacterial master alloy
将称量好的Ti颗粒和Cu颗粒按一定比例装入磁悬浮感应熔炼炉或电弧炉的坩埚中,将Cu颗粒掩埋在Ti颗粒中,经抽空排气至<0.001 Pa真空度后,在1.2 bar的氩气氛围保护下进行熔炼,熔炼温度为1800 ℃,熔炼时间为60秒,为使成分均匀,需翻身重复熔炼2次,切割成抗菌中间合金颗粒;The weighed Ti particles and Cu particles are loaded into the crucible of a magnetic suspension induction melting furnace or an arc furnace in a certain proportion, and the Cu particles are buried in the Ti particles. After evacuating the air to a vacuum degree of <0.001 Pa, the particles are melted under the protection of an argon atmosphere of 1.2 bar. The melting temperature is 1800 °C and the melting time is 60 seconds. In order to make the composition uniform, the particles need to be turned over and melted twice, and then cut into antibacterial master alloy particles.
步骤3:终体合金的制备Step 3: Preparation of final alloy
将CoCrMo中间合金颗粒和抗菌中间合金颗粒混合,Zr颗粒放置于顶部,CoCrMo中间合金颗粒和抗菌中间合金颗粒置于底部,装入磁悬浮感应熔炼炉的水冷铜坩埚内,经抽空排气至<0.001 Pa真空度后,在1.2 bar的氩气氛围保护下进行熔炼,熔炼温度为1800℃,熔炼时间为60秒,为使成分均匀,需翻身重复熔炼2次,得到促成骨TiZrCoCrMoCu抗菌中熵合金铸锭,此方法避免了熔炼Mo颗粒,可大幅提高熔炼成功率。The CoCrMo master alloy particles and the antibacterial master alloy particles are mixed, the Zr particles are placed on the top, and the CoCrMo master alloy particles and the antibacterial master alloy particles are placed on the bottom, and are loaded into a water-cooled copper crucible of a magnetic levitation induction melting furnace. After evacuating the air to a vacuum degree of <0.001 Pa, they are melted under the protection of an argon atmosphere of 1.2 bar. The melting temperature is 1800°C and the melting time is 60 seconds. In order to make the composition uniform, the ingot needs to be turned over and melted repeatedly twice to obtain a bone-promoting TiZrCoCrMoCu antibacterial medium-entropy alloy ingot. This method avoids the melting of Mo particles and can greatly improve the melting success rate.
图1为纯Ti样品与实施例1-3制得的促成骨TiZrCoCrMoCu抗菌中熵合金的ARS染色图,图2为纯Ti样品与实施例1-3所制备TiZrCoCrMoCu抗菌中熵合金的抗菌平板涂布图;图3是纯Ti样品与本发明实施例1-3所制备TiZrCoCrMoCu抗菌中熵合金的抗菌率柱状图;图4为纯Ti样品与实施例1-3所制备TiZrCoCrMoCu抗菌中熵合金的7天细胞增值率统计图;图5为纯Ti、Cu样品与实施例1-3所制备TiZrCoCrMoCu抗菌中熵合金的细胞骨架荧光染色图。Figure 1 is an ARS staining image of a pure Ti sample and the bone-promoting TiZrCoCrMoCu antibacterial medium-entropy alloy prepared in Example 1-3, Figure 2 is an antibacterial flat plate coating image of a pure Ti sample and the TiZrCoCrMoCu antibacterial medium-entropy alloy prepared in Example 1-3; Figure 3 is a bar graph of the antibacterial rate of a pure Ti sample and the TiZrCoCrMoCu antibacterial medium-entropy alloy prepared in Example 1-3 of the present invention; Figure 4 is a statistical graph of the 7-day cell proliferation rate of a pure Ti sample and the TiZrCoCrMoCu antibacterial medium-entropy alloy prepared in Example 1-3; Figure 5 is a cytoskeleton fluorescence staining image of pure Ti, Cu samples and the TiZrCoCrMoCu antibacterial medium-entropy alloy prepared in Example 1-3.
由图1可知,实施例1、2、3制备的TiZrCoCrMoCu抗菌中熵合金表面的矿化结节密度均比纯Ti高,实施例3制备的TiZrCoCrMoCu抗菌中熵合金拥有密度最高的矿化结节。从这些结果可以推断,Cu的加入对于促进细胞成骨具有正面作用,尤其是在Cu含量较高时(如实施例3)。这对于开发具有促进骨修复和抗菌能力的生物材料具有重要意义,表明通过调整Cu的浓度,可以优化材料的促成骨性能,为植入体材料的设计提供有价值的参考。As shown in Figure 1, the density of mineralized nodules on the surface of the TiZrCoCrMoCu antibacterial medium entropy alloys prepared in Examples 1, 2, and 3 is higher than that of pure Ti, and the TiZrCoCrMoCu antibacterial medium entropy alloy prepared in Example 3 has the highest density of mineralized nodules. From these results, it can be inferred that the addition of Cu has a positive effect on promoting cell osteogenesis, especially when the Cu content is high (such as in Example 3). This is of great significance for the development of biomaterials with the ability to promote bone repair and antibacterial properties, indicating that by adjusting the concentration of Cu, the osteogenic properties of the material can be optimized, providing a valuable reference for the design of implant materials.
图2、3可见,实施例1、2、3制备的TiZrCoCrMoCu抗菌中熵合金均具有抗菌能力,其抗菌率分别为27.90%、61.59%、95.12%。As shown in Figures 2 and 3, the TiZrCoCrMoCu antibacterial medium-entropy alloys prepared in Examples 1, 2, and 3 all have antibacterial capabilities, and their antibacterial rates are 27.90%, 61.59%, and 95.12%, respectively.
图4为细胞增值率图,对照组的纯Ti样品的细胞增殖率作为基准被设定为 100%。结果显示,对照组的细胞表现出正常的增殖能力,而实验组中熵合金样品(实施例 1、2、3)的细胞增值率分别达到了 110.07%、115.39%和 120.32%。这些数据清楚地表明,随着 Cu含量的增加,细胞增值率也相应提升,证明合金样品对细胞增殖起促进作用,并具有良好的生物相容性。特别是,实施例3的中合金表现出最高的细胞增值率,表明实施例3兼具高抗菌性和优秀的促成骨能力。Fig. 4 is a cell proliferation rate diagram, and the cell proliferation rate of the pure Ti sample of the control group is set to 100% as a benchmark. The results show that the cells of the control group show normal proliferation ability, while the cell proliferation rates of the entropy alloy samples (Examples 1, 2, and 3) in the experimental group reach 110.07%, 115.39%, and 120.32%, respectively. These data clearly show that with the increase of Cu content, the cell proliferation rate is also correspondingly improved, proving that the alloy sample promotes cell proliferation and has good biocompatibility. In particular, the alloy in Example 3 shows the highest cell proliferation rate, indicating that Example 3 has both high antibacterial properties and excellent osteogenic ability.
由图5可知,在纯Cu表面,细胞呈现出皱缩和破碎,并且数量相对较少。这种现象指纯Cu对细胞具有强烈的细胞毒性,导致细胞不能正常生长和繁殖。相比之下,纯Ti、实施例1、2、3制备的中熵合金表面的细胞数量不仅比纯Cu表面的多,而且与纯Ti相比也有所增加,尤其是在实施例3制备的中熵合金表面,细胞数量最为丰富,且细胞形态饱满,显示出健康的生长状态。这表明,在适当的Cu含量下,合金表面不仅没有表现出细胞毒性,反而促进了细胞的增殖和健康生长。在精确控制Cu含量的情况下,TiZrCoCrMoCu抗菌中熵合金能够显著促进成骨细胞生长具备优异的抗菌性能。这一发现对于合金材料在生物医用材料领域的应用具有重要意义,尤其是在需要促进细胞生长和组织再生的应用中,如骨科植入物和口腔种植体。As shown in Figure 5, on the surface of pure Cu, the cells show shrinkage and fragmentation, and the number is relatively small. This phenomenon refers to the strong cytotoxicity of pure Cu to cells, which causes the cells to be unable to grow and reproduce normally. In contrast, the number of cells on the surface of the medium entropy alloy prepared by pure Ti, Examples 1, 2, and 3 is not only more than that on the surface of pure Cu, but also increases compared with pure Ti, especially on the surface of the medium entropy alloy prepared in Example 3, the number of cells is the most abundant, and the cell morphology is full, showing a healthy growth state. This shows that under the appropriate Cu content, the alloy surface not only does not show cytotoxicity, but promotes cell proliferation and healthy growth. Under the condition of precise control of the Cu content, the TiZrCoCrMoCu antibacterial medium entropy alloy can significantly promote the growth of osteoblasts and has excellent antibacterial properties. This discovery is of great significance for the application of alloy materials in the field of biomedical materials, especially in applications where cell growth and tissue regeneration need to be promoted, such as orthopedic implants and oral implants.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410613492.5A CN118207464B (en) | 2024-05-17 | 2024-05-17 | Entropy alloy material for promoting bone TiZrCoCrMoCu to resist bacteria and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410613492.5A CN118207464B (en) | 2024-05-17 | 2024-05-17 | Entropy alloy material for promoting bone TiZrCoCrMoCu to resist bacteria and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN118207464A CN118207464A (en) | 2024-06-18 |
CN118207464B true CN118207464B (en) | 2024-07-23 |
Family
ID=91450510
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410613492.5A Active CN118207464B (en) | 2024-05-17 | 2024-05-17 | Entropy alloy material for promoting bone TiZrCoCrMoCu to resist bacteria and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN118207464B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114875293A (en) * | 2022-04-14 | 2022-08-09 | 湖南大学 | Ti-Zr-Nb-Ta-Cu high-entropy alloy, preparation method thereof and application thereof in medical antibacterial material |
CN116511429A (en) * | 2023-06-29 | 2023-08-01 | 西安稀有金属材料研究院有限公司 | Preparation method of large-size casting defect-free high-entropy alloy ingot with uniform components |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000077267A1 (en) * | 1999-06-11 | 2000-12-21 | Kabushiki Kaisha Toyota Chuo Kenkyusho | Titanium alloy and method for producing the same |
JP2002212664A (en) * | 2001-01-10 | 2002-07-31 | Furukawa Electric Co Ltd:The | NiTiAu ALLOY HAVING EXCELLENT X-RAY CONTRAST PROPERTY AND PARTS FOR MEDICAL USE CONSISTING OF THE ALLOY AND PROVIDED WITH X-RAY CONTRAST PROPERTY |
US20060100692A1 (en) * | 2004-11-09 | 2006-05-11 | Robert Burgermeister | Cobalt-chromium-molybdenum fatigue resistant alloy for intravascular medical devices |
-
2024
- 2024-05-17 CN CN202410613492.5A patent/CN118207464B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114875293A (en) * | 2022-04-14 | 2022-08-09 | 湖南大学 | Ti-Zr-Nb-Ta-Cu high-entropy alloy, preparation method thereof and application thereof in medical antibacterial material |
CN116511429A (en) * | 2023-06-29 | 2023-08-01 | 西安稀有金属材料研究院有限公司 | Preparation method of large-size casting defect-free high-entropy alloy ingot with uniform components |
Also Published As
Publication number | Publication date |
---|---|
CN118207464A (en) | 2024-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Xu et al. | Characteristics of novel Ti–10Mo-xCu alloy by powder metallurgy for potential biomedical implant applications | |
Balamurugan et al. | Corrosion aspects of metallic implants—An overview | |
JP2018021251A (en) | Biodegradable metal alloys | |
Wang et al. | Biofunctional magnesium coating of implant materials by physical vapour deposition | |
CN107190191B (en) | A kind of biological medical magnesium alloy and preparation method thereof | |
CN108998684A (en) | A kind of preparation method of copper titanium-based biomaterial | |
US20130150227A1 (en) | Composite Bio-Ceramic Dental Implant and Fabricating Method Thereof | |
CN107630151A (en) | A kind of new type beta type titanium alloy with antibacterial and promotion knitting function | |
CN109022853A (en) | A kind of preparation method of antibacterial Ti-Nb-Zr-Ag alloy pig | |
CN105349839B (en) | A kind of low elastic modulus β-Zr type biomedical alloys and preparation method thereof | |
Chen et al. | Impact of exogenous metal ions on peri-implant bone metabolism: a review | |
CN114540689A (en) | Antibacterial medical tantalum alloy with ultralow elastic modulus and preparation method thereof | |
CN108950443B (en) | Medical titanium alloy bar with antibacterial and osteoinductive activity functions | |
Bao et al. | β duplex phase Ti–Zr–Nb–Ag alloys with impressive mechanical properties, excellent antibacterial and good biocompatibility | |
Zhou et al. | Novel coatings for the continuous repair of human bone defects | |
Alagatu et al. | Review of different material and surface modification techniques for dental implants | |
CN105803254B (en) | A kind of preparation method of bulk titanium copper calcium biomaterial | |
CN111809090A (en) | A kind of medical degradable Mg-Pr series magnesium alloy and its preparation method and application | |
CN118207464B (en) | Entropy alloy material for promoting bone TiZrCoCrMoCu to resist bacteria and preparation method thereof | |
Shtansky et al. | Multifunctional bioactive nanostructured films | |
CN105671365A (en) | Preparation method of titanium-calcium-copper biological material | |
CN118773478A (en) | A copper-containing medical titanium alloy and preparation method thereof | |
CN116815107B (en) | Composite alloy material and preparation method and application thereof | |
WO2022198965A1 (en) | Titanium-molybdenum-based hydroxyapatite composite material for bone repair, and preparation method therefor | |
Cui et al. | Feasibility study on Ti-15Mo-7Cu with low elastic modulus and high antibacterial property |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |